Medication
Cambia
DIN 02381680 · Aralez Pharmaceuticals Canada Inc
What it is
- Active ingredients
- Diclofenac Potassium — 50 mg
- Form and route
- Powder For Solution · Oral
- Schedule
- PRESCRIPTION
- Authorised since
- 2012-06-02
Source: Health Canada — Drug Product Database. Data current as of 2026-08-12.
Products with the same active ingredient
- Voltaren Rapide
- Teva-Diclofenac-K
- Sandoz Diclofenac Rapide
- Riva-Diclofenac
- Jamp Diclofenac for Solution
- Taro-Diclofenac Potassium Powder for Oral Solution
Grouped by Health Canada’s active-ingredient group number. Products in a group do not always share a strength — check the strength above against your own. Sharing an active ingredient does not mean two products can be substituted for each other: whether a substitution is permitted is a provincial decision, and this page does not show it. Ask a pharmacist.
Ontario Drug Benefit coverage
As of 31 July 2026Off-formulary interchangeable Part III-B
Ontario has designated this product interchangeable with a brand product, but it is not an ODB benefit — Part III-B, Off-Formulary Interchangeable. Ontario does not pay for it under the benefit list.
Source: Ontario Ministry of Health — ODB Formulary. Data current as of 2026-07-28. Ontario only. Formulary edition 4342, effective 31 July 2026.
Products Ontario considers interchangeable
As of 31 July 2026Ontario groups these products together at 50mg/Sachet Pwd for Sol and will substitute one for another at a pharmacy counter in Ontario.
- Jamp Diclofenac for Solution 02563290Jamp Pharma Corporation
- Riva-Diclofenac 02560631Laboratoire Riva Inc.
- Taro-Diclofenac Potassium Powder for Oral Solution 02564475Taro Pharmaceuticals Inc
This is Ontario’s designation, under the Ontario Drug Benefit program, and it applies in Ontario. It is a different statement from the same-active-ingredient list above, which is Health Canada’s grouping and carries no substitution meaning at all. No other province’s rules are shown on this page, and a designation here is not a recommendation to switch — that is a conversation with a pharmacist or prescriber.
Source: Ontario Ministry of Health — ODB Formulary. Data current as of 2026-07-28. Ontario only. Formulary edition 4342, effective 31 July 2026.
How it is classified
- Anatomical main group
- Musculo-skeletal system
- ATC code
- M01AB05
The Anatomical Therapeutic Chemical code records the body system a medicine acts on and its chemical grouping. It is not a statement of what this medication treats, and nothing on this page is. For the full classification of M01AB05, see the WHO ATC/DDD Index.
Recalls and safety alerts
As of 12 August 2026No Health Canada recall has been matched to this product.
This is not a statement that no recall exists for this medication. Health Canada’s recalls data carries no DIN and no company name, so notices are matched on wording alone — and 1,437 of the 2,306 drug notices in the feed could not be matched to any product at all. Check Health Canada’s own search before concluding anything.
Search Health Canada recalls for Cambia →
How RxMonitor matches recalls, and how often it fails
Source: Health Canada — Recalls and Safety Alerts. Data current as of 2026-08-12. Matched on product name, not on DIN — the feed carries none.